| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/19/1997 | EP0730568A4 Amphiphilic derivatives of piperazine |
| 02/19/1997 | EP0730405A4 Amphiphilic derivatives of guanidine |
| 02/19/1997 | EP0730404A4 Amphiphilic imidazolinium derivatives |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143374A Non-viral vector |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/13/1997 | WO1997005267A2 Mucosal delivery of polynucleotides |
| 02/13/1997 | WO1997005266A1 Methods and means for targeted gene delivery |
| 02/13/1997 | WO1997005265A1 Transport proteins and their uses |
| 02/13/1997 | WO1997005264A1 Improvements in or relating to delivery of nucleic acid |
| 02/13/1997 | WO1997005256A2 Mammalian pro-hormone convertase |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005254A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 02/13/1997 | WO1997005249A2 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005185A2 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents |
| 02/13/1997 | WO1997005157A1 Gene encoding the human homolog of mad2 |
| 02/13/1997 | WO1997004810A1 Dax-1 protein, methods for production and use thereof |
| 02/13/1997 | WO1997004787A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996034969A3 Gene therapy using replication competent targeted adenoviral vectors |
| 02/13/1997 | WO1995027071A3 An adenovirus supervector system |
| 02/13/1997 | CA2228378A1 Cytidine deaminase cdna as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 02/13/1997 | CA2228374A1 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/13/1997 | CA2228118A1 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents |
| 02/13/1997 | CA2227989A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | CA2227988A1 Mammalian pro-protein converting enzyme |
| 02/13/1997 | CA2227871A1 Mucosal delivery of polynucleotides |
| 02/13/1997 | CA2227786A1 Transport proteins and their uses |
| 02/13/1997 | CA2227770A1 Improvements in or relating to delivery of nucleic acid |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | CA2224907A1 Methods and means for targeted gene delivery |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/11/1997 | US5602306 Transgenic pig expressing human hemoglobin |
| 02/11/1997 | US5602301 Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |
| 02/06/1997 | WO1997004119A1 Viral vectors and line for gene therapy |
| 02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | WO1997004117A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004001A1 Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003702A1 A method for gene therapy using nucleic acid loaded polymeric microparticles |
| 02/06/1997 | WO1997003657A1 A process for preparing microparticles through phase inversion phenomena |
| 02/06/1997 | WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 02/06/1997 | WO1996036314A3 Method for drug delivery to the pulmonary system |
| 02/06/1997 | DE19528544A1 cDNA-Sequenz und daraus abgeleitete Aminosäuresequenz des Vorläuferproteins von humanem GCAP II/Uroguanylin sowie Aminosäuresequenz des im humanen Blut zirkulierenden Fragmentes cDNA sequence and deduced amino acid sequence of the precursor protein of human GCAP II / uroguanylin and amino acid sequence of the human blood circulating in the fragment |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227287A1 A method for gene therapy using nucleic acid loaded polymeric microparticles |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227193A1 P16 expression constructs and their application in cancer therapy |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | CA2226926A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2200696A1 Viral vectors and line for gene therapy |
| 02/05/1997 | EP0756638A1 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756601A1 Compositions and methods for cell transformation |
| 02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
| 02/05/1997 | CN1142247A Extracorporeal ceel culture and transplantation kits |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1141953A Formation of plasmid-type herpes-virus carrier for specific expression of human nerve cell and usage of same |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
| 02/04/1997 | US5599712 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 02/04/1997 | US5599706 Ribozymes targeted to apo(a) mRNA |
| 02/04/1997 | US5599705 In vitro method for producing differentiated universally compatible mature human blood cells |
| 01/30/1997 | WO1997003345A2 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna |
| 01/30/1997 | WO1997003211A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | WO1997003203A2 Generation of immune responses to prostate-specific antigen (psa) |
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003187A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | WO1997003087A1 Novel regulatory genes |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002841A1 Genetic therapy employing the hhv-6a derived ts gene or polypeptide |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1996038555A3 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226362A1 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | CA2223645A1 Antisense inhibition of hepatitis b virus replication |
| 01/29/1997 | EP0756006A2 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755454A1 Aav-mediated delivery of dna to cells of the nervous system |
| 01/29/1997 | EP0755452A1 Method and composition for regulating apoptosis |
| 01/29/1997 | EP0755450A1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 01/29/1997 | EP0755445A1 Cell-cycle regulatory proteins, and uses related thereto |